OBJECTIVES: To investigate prognostic outcomes and utilization of medical services by patients with Parkinson disease (PD) and to identify predictors of such use. PATIENTS AND METHODS: Using the medical records linkage system of the Rochester Epidemiology Project, we identified an incidence cohort of 89 PD cases (Olmsted County, Minnesota, 1979-1988) and a reference group of 89 subjects without PD of the same age and sex and from the same population. Both patients with PD and reference subjects were followed up historically by medical record review from onset of PD (or index year) through death, last contact with the system, or end of study. RESULTS: Patients with PD had significantly more physician consultations per year (median, 7.9 vs 5.9; P=.001) and more emergency department visits per year (median, 0.6 vs 0.4; P=.05) than did reference subjects. Response to dopaminergic medications and higher education predicted more physician consultations among patients. The PD patients used neuroleptics and antidepressants significantly more frequently than reference subjects. The risk of nursing home placement was significantly increased for PD patients compared with reference subjects (relative risk, 6.7; 95% confidence interval, 3.7-12.1; P<.001). Poor response to dopaminergic medications, lower education level, older age at onset of PD, and dementia predicted a shorter time between onset and nursing home placement among PD patients. Survival was significantly reduced in PD patients compared with reference subjects (relative risk, 2.2; 95% confidence interval, 1.4-3.4; P<.001). Good response to dopaminergic medications, higher education, younger age at onset of PD, and absence of dementia predicted better survival among PD patients. CONCLUSIONS: Patients with PD used outpatient and nursing home services more often than subjects without PD. Patients with PD also experienced a reduced survival time. Demographic and clinical characteristics influenced utilization patterns and outcomes.
OBJECTIVES: To investigate prognostic outcomes and utilization of medical services by patients with Parkinson disease (PD) and to identify predictors of such use. PATIENTS AND METHODS: Using the medical records linkage system of the Rochester Epidemiology Project, we identified an incidence cohort of 89 PD cases (Olmsted County, Minnesota, 1979-1988) and a reference group of 89 subjects without PD of the same age and sex and from the same population. Both patients with PD and reference subjects were followed up historically by medical record review from onset of PD (or index year) through death, last contact with the system, or end of study. RESULTS:Patients with PD had significantly more physician consultations per year (median, 7.9 vs 5.9; P=.001) and more emergency department visits per year (median, 0.6 vs 0.4; P=.05) than did reference subjects. Response to dopaminergic medications and higher education predicted more physician consultations among patients. The PDpatients used neuroleptics and antidepressants significantly more frequently than reference subjects. The risk of nursing home placement was significantly increased for PDpatients compared with reference subjects (relative risk, 6.7; 95% confidence interval, 3.7-12.1; P<.001). Poor response to dopaminergic medications, lower education level, older age at onset of PD, and dementia predicted a shorter time between onset and nursing home placement among PDpatients. Survival was significantly reduced in PDpatients compared with reference subjects (relative risk, 2.2; 95% confidence interval, 1.4-3.4; P<.001). Good response to dopaminergic medications, higher education, younger age at onset of PD, and absence of dementia predicted better survival among PDpatients. CONCLUSIONS:Patients with PD used outpatient and nursing home services more often than subjects without PD. Patients with PD also experienced a reduced survival time. Demographic and clinical characteristics influenced utilization patterns and outcomes.
Authors: Lianna S Ishihara; Anne Cheesbrough; Carol Brayne; Anette Schrag Journal: J Neurol Neurosurg Psychiatry Date: 2007-03-30 Impact factor: 10.154
Authors: Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick Journal: Int J Geriatr Psychiatry Date: 2017-02-01 Impact factor: 3.485
Authors: Sotirios A Parashos; Sheng Luo; Kevin M Biglan; Ivan Bodis-Wollner; Bo He; Grace S Liang; G Webster Ross; Barbara C Tilley; Lisa M Shulman Journal: JAMA Neurol Date: 2014-06 Impact factor: 18.302
Authors: Amit Chopra; Susannah J Tye; Kendall H Lee; Shirlene Sampson; Joseph Matsumoto; Andrea Adams; Bryan Klassen; Matt Stead; Julie A Fields; Mark A Frye Journal: J Neuropsychiatry Clin Neurosci Date: 2012 Impact factor: 2.198
Authors: Michael J Aminoff; Chad W Christine; Joseph H Friedman; Kelvin L Chou; Kelly E Lyons; Rajesh Pahwa; Bastian R Bloem; Sotirios A Parashos; Catherine C Price; Irene A Malaty; Robert Iansek; Ivan Bodis-Wollner; Oksana Suchowersky; Wolfgang H Oertel; Jorge Zamudio; Joyce Oberdorf; Peter Schmidt; Michael S Okun Journal: Parkinsonism Relat Disord Date: 2010-12-14 Impact factor: 4.891